Related references
Note: Only part of the references are listed.Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Manisha H. Shah et al.
Journal of the National Comprehensive Cancer Network (2021)
PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations
Marius E. Mayerhoefer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
Romain Eychenne et al.
MOLECULES (2020)
The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future
Virginia Liberini et al.
DIAGNOSTICS (2020)
Performance of 68Ga-DOTA-Conjugated Somatostatin Receptor-Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis
Sangwon Han et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
111In-Pentetreotide Scintigraphy Versus 68Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden
Thomas A. Hope et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Preparing data for multiparametric PET/MR imaging: Influence of PET point spread function modelling and EPI distortion correction on the spatial correlation of [18F]FDG-PET and diffusion-weighted MRI in head and neck cancer
Anders Olin et al.
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2019)
68Ga-DOTATATE PET: temporal variation of maximum standardized uptake value in normal tissues and neuroendocrine tumours
George Barberio Coura-Filho et al.
NUCLEAR MEDICINE COMMUNICATIONS (2019)
Pheochromocytoma and Paraganglioma
Hartmut P. H. Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
PET/MRI for neuroendocrine tumors: a match made in heaven or just another hype?
Ali Pirasteh et al.
CLINICAL AND TRANSLATIONAL IMAGING (2019)
Pathology and genetics of phaeochromocytoma and paraganglioma
John Turchini et al.
HISTOPATHOLOGY (2018)
Clinical PET/MRI: 2018 Update
Stephen M. Broski et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
Fast non-enhanced abdominal examination protocols in PET/MRI for patients with neuroendocrine tumors (NET): comparison to multiphase contrast-enhanced PET/CT
Ferdinand Seith et al.
RADIOLOGIA MEDICA (2018)
Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications
Rudolf A. Werner et al.
ANNALS OF NUCLEAR MEDICINE (2018)
New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Joakim Crona et al.
ENDOCRINE REVIEWS (2017)
Clinical evaluation of whole-body oncologic PET with time-of-flight and point-spread function for the hybrid PET/MR system
Kun Shang et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT
Lino M. Sawicki et al.
EUROPEAN RADIOLOGY (2017)
Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years
Oksana Hamidi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients
Dominik Berzaczy et al.
CLINICAL NUCLEAR MEDICINE (2017)
Impact of Point-Spread Function Modeling on PET Image Quality in Integrated PET/MR Hybrid Imaging
Bassim Aklan et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Design Features and Mutual Compatibility Studies of the Time-of-Flight PET Capable GE SIGNA PET/MR System
Craig S. Levin et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2016)
Quantitative comparison of PET performance-Siemens Biograph mCT and mMR
Anna M. Karlberg et al.
EJNMMI PHYSICS (2016)
Simultaneous 68Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor
Thomas A. Hope et al.
ABDOMINAL IMAGING (2015)
Integrated Whole-Body PET/MRI With 18F-FDG, 18F-FDOPA, and 18F-FDA in Paragangliomas in Comparison With PET/CT NIH First Clinical Experience With a Single-Injection, Dual-Modality Imaging Protocol
Elise M. Blanchet et al.
CLINICAL NUCLEAR MEDICINE (2014)
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
Jacques W. M. Lenders et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Simultaneous 68Ga-DOTATOC PET/MRI in Patients With Gastroenteropancreatic Neuroendocrine Tumors Initial Results
Karsten J. Beiderwellen et al.
INVESTIGATIVE RADIOLOGY (2013)
Share Paper
